SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ajanta Pharma informs about outcome of AGM

18 Jul 2025 Evaluate

Ajanta Pharma has informed that the 46th Annual General Meeting (AGM) of the company was held on Thursday, 17th July 2025 at 11.00 am through Video Conferencing /Other Audio-Visual Means. The company has informed that AGM proceedings have been submitted separately. Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has submitted the following: a. Details of voting results through remote e-voting and at the AGM on each of the resolutions set out in the notice; b. Consolidated Scrutinizer’s Report dated 17th July 2025 on remote e-voting and at the AGM. The above results are uploaded on the website of the company at www.ajantapharma.com.

The above information is a part of company’s filings submitted to BSE. 

Ajanta Pharma Share Price

3050.00 17.80 (0.59%)
11-May-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1282.15
Cipla 1304.70
Zydus Lifesciences 960.00
Lupin 2249.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×